PT  - JOURNAL ARTICLE
AU  - Long, Cheng
AU  - Fu, Xinmiao
TI  - Forecasting COVID-19 cases and deaths in epidemic-mitigating European countries by Richards function-based regression analyses
AID  - 10.1101/2020.05.18.20106146
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.18.20106146
4099  - http://medrxiv.org/content/early/2020/05/26/2020.05.18.20106146.short
4100  - http://medrxiv.org/content/early/2020/05/26/2020.05.18.20106146.full
AB  - The COVID-19 pandemic has hit many countries, and in some European countries it has been mitigated since April. Here we applied Richards function to simulate and forecast the course of COVID-19 epidemics in Italy, Spain, France, Germany, Turkey, Belgium, Ireland, Netherlands, Portugal and Switzerland. Potential total COVID-19 confirmed cases in these countries were estimated to be 240400±1300, 294100±4000, 178500±800, 176900±700, 155400±1000, 57900±400, 24000±200, 46200±300, 30000±300 and 30700±100 respectively. Most of these countries are predicted to approach ending stage between late May and early June such that daily new cases will become minimal, which may guide societal and economic restorations. In addition, total COVID-19 deaths were estimated to be 33500 ±300, 28200±200, 27800±200, 8740±80, 4500 ±30, 9250±70, 1530±20, 6240±50, 1380±10 and 1960±8, respectively. To our best knowledge, this is the first study forecasting the COVID-19 epidemic by applying the Richard function-based regression analysis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is support by the National Natural Science Foundation of China (No. 31972918 and 31770830 to XF).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are included in the manuscript